26 Mar 2026 13:10 CET

Issuer

AKER BIOMARINE ASA

26 March 2026: The annual general meeting of Aker BioMarine ASA will be held on
Tuesday 28 April 2026 at 13:00 CEST.

The meeting will be conducted as a virtual meeting only, and voting will be
handled online during the meeting. Information about log-in details for the
meeting is available in the notice of
the general meeting. For further information regarding participation, please go
to www.akerbiomarine/agm.

No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Deadline for registration of advance votes and
proxies is 24 April 2026 at 16:00 CEST.

Please find attached the following documents
- Notice and Proxy forms for the Annual General Meeting 2026
- Proposed Resolutions for the Annual General Meeting 2026
- Management Remuneration Report 2025
- Proposal from the Nomination Committee

All documents to be processed in the meeting are available on
www.akerbiomarine/agm.

For further information, please contact
Christopher Robin Vinter, SVP Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.


669424_AKBM Management remuneration report 2025.pdf
669424_AKBM - Notice of AGM 28 April 2026 with proxy form.pdf
669424_Proposed Resolutions for the Annual General Meeting 2026.pdf
669424_Proposal from the Nomination Committee of Aker BioMarine ASA 2026.pdf

Source

Aker BioMarine ASA

Provider

Oslo Børs Newspoint

Company Name

AKER BIOMARINE ASA, Aker Biomarine ASA 24/27 FRN C

ISIN

NO0010886625, NO0013326025

Symbol

AKBM

Market

Euronext Oslo Børs